研究和试验发展
- A股行业
- 行业公司
研究和试验发展A股上市公司
共 31 家，按总市值从高到低排序。财务数据为2026年Q1。
| 公司 | 总市值（亿） | TTM 市盈率 | 营收同比 | 净利同比 |
|---|---|---|---|---|
| 药明康德603259 | 3268.71 | 17.57x | +28.8% | +26.7% |
| 康龙化成300759 | 538.51 | 40.14x | +15.5% | +9.8% |
| 泰格医药300347 | 475.29 | 242.28x | +15.2% | -70.4% |
| 百奥赛图688796 | 430.5 | 103.45x | +73.7% | +885.4% |
| 昭衍新药603127 | 291.27 | 30.55x | +10.0% | +479.7% |
| 皓元医药688131 | 158.14 | 58.28x | +20.2% | +8.8% |
| 成都先导688222 | 114.63 | 69.06x | +50.4% | +46.7% |
| 益诺思688710 | 94.46 | 193.42x | +0.4% | +121.2% |
| 药石科技300725 | 93.17 | 47.65x | +11.7% | +36.6% |
| 义翘神州301047 | 86.42 | 67.21x | +18.1% | +42.0% |
| 美迪西688202 | 84.99 | 136.07x | +36.5% | +207.3% |
| 药康生物688046 | 84.46 | 44.83x | +21.8% | +57.1% |
| 诺唯赞688105 | 79.35 | 474.38x | +12.5% | +119.0% |
| 百普赛斯301080 | 74.73 | 40.39x | +26.3% | +14.0% |
| 阿拉丁688179 | 71.36 | 61.32x | +31.1% | +20.3% |
| 奥浦迈688293 | 69.97 | 44.59x | +117.7% | +167.4% |
| 阳光诺和688621 | 64.6 | 78.28x | -14.6% | -30.2% |
| 百诚医药301096 | 63.96 | 124.81x | +24.6% | +148.9% |
| 诺思格301333 | 61.58 | 67.45x | +26.2% | -12.5% |
| 诺禾致源688315 | 59.23 | 50.28x | +10.8% | -13.1% |
| 泓博医药301230 | 57.79 | 60.76x | +1.7% | +98.6% |
| 毕得医药688073 | 57.73 | 30.82x | +9.1% | +52.6% |
| 睿智医药300149 | 49.75 | -68.5x | +2.1% | -373.4% |
| 和元生物688238 | 44.07 | -20.75x | -4.4% | +10.8% |
| 博济医药300404 | 41.44 | 62.94x | +58.5% | +322.0% |
| 普蕊斯301257 | 41.4 | 86.07x | +9.9% | +61.8% |
| 泰坦科技688133 | 36.92 | -28.5x | -3.5% | -731.4% |
| 近岸蛋白688137 | 34.02 | -80.21x | +11.4% | +10.2% |
| 百花医药600721 | 32.42 | 122x | -30.7% | -67.9% |
| 南模生物688265 | 32.28 | 1180.34x | +13.0% | +170.7% |
| 万邦医药301520 | 28.31 | -2703.27x | -57.0% | -102.2% |
其他行业
本页面内容仅基于公开财务数据整理，不构成投资建议。股市有风险，投资需谨慎。